Evidence map›Paper›PMID 40719879›Full record

ReviewDermatologie (Heidelberg, Germany)2025

[Overview of clinical manifestations, diagnosis and management of acute allergic disorders].

Pia-Charlotte Stadler, Charlotte Gust, Stefan Weißinger, Lars E French, Eva M Oppel

Abstract readReviewEnglish Abstract
PubMed Publisher
In one paragraph

Review in Dermatologie (Heidelberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Pia-Charlotte StadlerKlinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.
Charlotte GustKlinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.
Stefan WeißingerKlinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.
Lars E FrenchKlinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland.
Eva M OppelKlinik und Poliklinik für Dermatologie und Allergologie, Klinikum der Universität München, LMU München, Frauenlobstr. 9-11, 80337, München, Deutschland. Eva.Oppel@med.uni-muenchen.de.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Allergological emergencies represent a particular challenge in clinical practice, as they require rapid identification and appropriate treatment to prevent serious complications and life-threatening courses. These emergencies primarily include life-threatening systemic hypersensitivity reactions-anaphylaxis-which can manifest on the skin as generalized urticaria and the development of angioedema, as well as severe cutaneous adverse drug reactions (SCADR). Among these, toxic epidermal necrolysis (TEN) represents the most severe one with a mortality rate of up to 30%. In the following article, we will discuss the current state-of-the-art diagnostics and treatment strategies for these dermatological emergencies and highlight new and promising therapeutic approaches.

Indexed as

HypersensitivityAcute DiseaseAnaphylaxisAngioedemaDiagnosis, DifferentialHumansStevens-Johnson SyndromeUrticariaAdverse drug reactionAnaphylaxisAngioedemaToxic epidermal necrolysisUrticaria

Identifiers

PMID40719879

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.